Document is current

Any future updates will be listed below

Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL

Crossref DOI link: https://doi.org/10.1038/s41571-024-00980-1

Published Online: 2024-12-17

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark